Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis

BACKGROUND: In recent years, a large amount of clinical evidence and animal experiments have demonstrated the unique advantages of mineralocorticoid receptor antagonists (MRA) for treating chronic kidney disease (CKD). AIMS: Accordingly, the present study aimed to systematically assess the second-ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Honglei, Cao, Mengdie, Sun, Yao, Jin, Xingqian, Zhao, Xiaodong, Cong, Xiangguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019978/
https://www.ncbi.nlm.nih.gov/pubmed/36938116
http://dx.doi.org/10.1155/2023/6683987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019978/
https://www.ncbi.nlm.nih.gov/pubmed/36938116
http://dx.doi.org/10.1155/2023/6683987

Ejemplares similares